Owkin

Owkin is using artificial intelligence to identify new treatments and diagnostics. Cancer is a highly heterogeneous disease, with one cancer tissue containing many subtypes that may respond differently to treatments. By exploiting this additional layer of information that can be gathered from pathology slides, Owkin is offering solutions to give healthcare providers a fuller picture of a patient’s disease such that more patients can benefit from targeted therapies. However, Owkin is also using AI to identify new drug candidates, de-risk and accelerate clinical trials as well as building diagnostic solutions.